patient
copd
prone
frequent
exacerb
import
determin
health
statu
patient
elev
airway
cytokin
level
suggest
presenc
increas
inflamm
may
increas
suscept
exacerb
inflammatori
respons
copd
exacerb
variabl
increas
level
exacerb
relat
presenc
common
cold
rhinoviru
infect
import
etiolog
factor
copd
exacerb
import
target
prevent
therapi
reduct
copd
exacerb
import
impact
consider
morbid
mortal
associ
copd
chest
consider
interest
caus
mechan
exacerb
copd
exacerb
import
caus
consider
morbid
mortal
found
patient
copd
copd
exacerb
increas
increas
diseas
sever
patient
prone
frequent
exacerb
constitut
import
caus
hospit
admiss
readmiss
exacerb
may
consider
impact
qualiti
life
activ
daili
live
copd
exacerb
also
associ
consider
physiolog
deterior
increas
airway
inflammatori
chang
caus
variou
factor
virus
bacteria
possibl
common
pollut
fig
copd
exacerb
common
winter
month
may
import
interact
cold
temperatur
exacerb
caus
virus
pollut
earlier
descript
copd
exacerb
concentr
mainli
studi
hospit
admiss
although
exacerb
treat
commun
associ
hospit
admiss
cohort
patient
moderatetosever
copd
observ
east
london
copd
studi
mean
daili
diari
card
peak
flow
read
ask
report
exacerb
soon
possibl
symptomat
onset
diagnosi
copd
exacerb
base
criteria
modifi
describ
anthonisen
colleagu
requir
two
symptom
diagnosi
one
must
major
symptom
increas
dyspnea
sputum
volum
sputum
purul
minor
exacerb
symptom
includ
cough
wheez
sore
throat
nasal
discharg
fever
studi
found
exacerb
went
unreport
research
team
despit
consider
encourag
diagnos
diari
card
although
differ
major
symptom
physiolog
paramet
report
unreport
exacerb
patient
copd
accustom
frequent
symptom
chang
thu
may
tend
underreport
exacerb
physician
patient
high
level
anxieti
depress
may
accept
situat
tendenc
patient
underreport
exacerb
may
explain
total
rate
exacerb
exacerb
per
patient
per
year
higher
previous
report
anthonisen
cowork
exacerb
per
patient
per
year
latter
studi
howev
exacerb
unreport
diagnos
patient
recal
symptom
use
median
number
exacerb
cutoff
point
copd
patient
east
london
studi
classifi
frequent
infrequ
exacerb
qualityoflif
score
measur
use
valid
diseasespecif
scale
ie
st
georg
respiratori
questionnair
significantli
wors
three
compon
score
ie
symptom
activ
impact
among
frequent
exacerb
compar
infrequ
exacerb
suggest
exacerb
frequenc
import
determin
health
statu
among
patient
copd
thu
one
import
outcom
measur
diseas
factor
predict
frequent
exacerb
includ
daili
cough
sputum
frequent
exacerb
previou
year
previou
studi
acut
infect
exacerb
chronic
bronchiti
found
one
factor
predict
exacerb
also
number
exacerb
experienc
previou
year
studi
howev
limit
patient
exacerb
present
purul
sputum
physiolog
data
avail
studi
prospect
analysi
exacerb
daili
monitor
perform
deterior
symptom
report
although
signific
peak
flow
chang
fall
peak
flow
fev
exacerb
gener
small
use
predict
exacerb
larger
fall
peak
flow
associ
symptom
dyspnea
presenc
cold
relat
longer
recoveri
time
exacerb
symptom
dyspnea
common
cold
sore
throat
cough
increas
significantli
prodrom
phase
suggest
respiratori
virus
may
earli
effect
exacerb
median
time
recoveri
peak
flow
day
median
time
recoveri
symptom
day
day
peak
flow
return
normal
patient
experienc
exacerb
day
patient
experienc
exacerb
return
baselin
level
lung
function
recoveri
longer
presenc
increas
dyspnea
symptom
common
cold
exacerb
chang
observ
lung
function
copd
exacerb
smaller
observ
asthmat
exacerb
although
averag
durat
asthmat
exacerb
longer
day
reason
incomplet
recoveri
symptom
lung
function
clear
may
involv
inadequ
treatment
persist
caus
agent
incomplet
physiolog
recoveri
exacerb
could
contribut
declin
lung
function
time
among
patient
copd
howev
date
evid
report
patient
incomplet
recoveri
exacerb
greater
declin
lung
function
studi
natur
histori
copd
exacerb
requir
associ
symptom
increas
dyspnea
common
cold
exacerb
prolong
recoveri
suggest
viral
infect
may
lead
prolong
exacerb
cold
associ
longer
exacerb
copd
patient
develop
cold
may
prone
sever
exacerb
consid
earli
therapi
onset
symptom
although
often
assum
exacerb
associ
increas
airway
inflamm
littl
inform
avail
natur
inflammatori
marker
especi
studi
close
occurr
exacerb
perform
bronchial
biopsi
exacerb
difficult
patient
moderatetosever
copd
relationship
airway
inflammatori
chang
symptom
physiolog
chang
exacerb
copd
also
import
factor
consid
one
studi
biopsi
perform
exacerb
patient
chronic
bronchiti
increas
airway
eosinophilia
found
although
patient
studi
mild
copd
exacerb
modest
increas
observ
neutrophil
lymphocyt
tumor
necrosi
cell
chang
number
cell
macrophag
mast
cell
howev
techniqu
sputum
induct
allow
studi
patient
exacerb
shown
safe
welltoler
copd
patient
level
inflammatori
cytokin
shown
elev
induc
sputum
copd
patient
condit
stabl
although
chang
exacerb
studi
previous
prospect
follow
cohort
patient
east
london
copd
studi
presenc
inflammatori
marker
induc
sputum
relat
symptom
physiolog
paramet
baselin
exacerb
relationship
exacerb
frequenc
level
sputum
cytokin
increas
level
interleukin
il
found
sputum
patient
stabl
baselin
experienc
frequent
exacerb
compar
experienc
infrequ
exacerb
fig
although
relationship
level
cytokin
baselin
lung
function
sputum
cell
count
higher
baselin
patient
frequent
exacerb
suggest
increas
cytokin
product
came
bronchial
epithelium
patient
copd
discuss
exacerb
trigger
viral
infect
especi
rhinoviru
caus
common
cold
rhinoviru
shown
increas
cytokin
product
epitheli
cell
line
thu
repeat
viral
infect
may
lead
upregul
cytokin
airway
express
exacerb
increas
found
level
induc
sputum
level
higher
exacerb
associ
symptom
common
cold
fig
experiment
rhinoviru
infect
shown
increas
sputum
level
healthi
subject
asthmat
patient
rise
cell
count
increas
level
howev
variabl
exacerb
reach
statist
signific
suggest
mark
heterogen
degre
inflammatori
respons
exacerb
level
exacerb
relat
sputum
neutrophil
total
cell
count
indic
neutrophil
recruit
major
sourc
airway
exacerb
airway
level
shown
increas
presenc
experiment
rhinoviru
infect
healthi
asthmat
patient
studi
other
howev
copd
patient
alreadi
upregul
airway
express
stabl
due
high
sputum
neutrophil
load
increas
level
would
unlik
copd
exacerb
associ
less
pronounc
airway
inflammatori
respons
asthmat
exacerb
may
explain
rel
reduc
respons
corticosteroid
therapi
seen
exacerb
copd
patient
compar
respons
exacerb
asthma
patient
studi
bhowmik
colleagu
increas
seen
eosinophil
count
exacerb
although
patient
studi
sampl
earli
exacerb
onset
symptom
compar
studi
saetta
colleagu
patient
mild
copd
patient
sever
irrevers
airflow
obstruct
fev
predict
possibl
therefor
inflammatori
respons
exacerb
differ
natur
patient
moderatetosever
copd
milder
case
copd
patient
followedup
daili
diari
card
studi
bhowmik
et
al
thu
inflammatori
marker
could
relat
exacerb
recoveri
relationship
degre
inflammatori
cell
respons
exacerb
durat
symptom
number
lung
function
chang
level
marker
induc
sputum
obtain
week
exacerb
show
relationship
exacerb
chang
thu
level
induc
sputum
marker
exacerb
predict
subsequ
cours
exacerb
use
predict
exacerb
sever
copd
exacerb
associ
number
etiolog
factor
includ
respiratori
infect
pollut
episod
tabl
viral
infect
import
trigger
copd
exacerb
frequent
trigger
upper
respiratori
tract
infect
infect
common
winter
month
respiratori
viral
infect
present
commun
patient
also
may
prone
exacerb
winter
month
lung
function
copd
patient
shown
small
signific
fall
reduct
outdoor
temperatur
winter
month
studi
childhood
asthma
shown
virus
especi
rhinoviru
caus
common
cold
detect
polymeras
chain
reaction
larg
number
exacerb
rhinoviru
hitherto
consid
much
signific
exacerb
copd
studi
patient
chronic
bronchiti
perform
year
scott
colleagu
found
rhinoviru
exacerb
chronic
bronchiti
detail
studi
chronic
bronchiti
patient
experienc
exacerb
year
gump
et
al
found
exacerb
could
attribut
rhinovirus
recent
studi
episod
copd
exacerb
use
serolog
method
nasal
sampl
viral
cultur
littl
evid
found
rhinoviru
etiolog
copd
exacerb
two
recent
studi
report
least
one
third
copd
exacerb
associ
viral
infect
major
due
rhinoviru
viral
exacerb
associ
symptomat
cold
prolong
recoveri
howev
seemung
colleagu
show
rhinoviru
recov
induc
sputum
frequent
nasal
aspir
exacerb
suggest
wildtyp
rhinoviru
infect
lower
airway
contribut
inflammatori
chang
exacerb
also
found
patient
exacerb
associ
presenc
rhinoviru
induc
sputum
larger
increas
airway
level
suggest
virus
increas
sever
airway
inflamm
exacerb
find
agreement
data
respiratori
virus
produc
longer
sever
exacerb
major
impact
healthcar
util
virus
may
trigger
copd
exacerb
although
coronaviru
associ
small
proport
asthmat
exacerb
unlik
play
major
role
copd
number
mechan
may
involv
associ
virus
exacerb
major
group
rhinoviru
account
total
rhinoviru
type
attach
airway
epithelium
intercellular
adhes
molecul
icam
induc
express
therebi
promot
inflammatori
cell
recruit
activ
seen
exacerb
minor
rhinoviru
group
use
member
ldlreceptor
famili
cell
surfac
receptor
although
surfac
express
also
may
upregul
evid
upregul
bronchial
mucosa
patient
chronic
bronchiti
may
repres
import
therapeut
target
copd
exacerb
associ
rhinovirus
viral
infect
associ
increas
oxid
stress
increas
copd
exacerb
rhinoviru
infect
human
respiratori
epitheli
cell
increas
product
reactiv
oxygen
speci
stimul
activ
nuclear
factorb
import
regul
gene
patient
experiment
rhinoviru
infect
nasal
level
relat
common
cold
symptom
viral
infect
also
induc
express
stressrespons
gene
eg
gene
encod
antioxid
enzym
eg
glutathion
peroxidas
mnsuperoxid
dismutas
may
import
potenti
effect
viral
mediat
inflamm
copd
exacerb
also
shown
exacerb
associ
increas
airway
system
level
import
bronchoconstrictor
peptid
found
proinflammatori
also
implic
pathogenesi
viral
mediat
inflamm
sputum
level
increas
copd
exacerb
relat
sputum
level
work
specif
endothelin
receptor
antagonist
may
provid
new
therapeut
option
inflamm
associ
copd
exacerb
associ
describ
chronic
bronchiti
death
cardiovascular
diseas
plasma
fibrinogen
independ
risk
factor
cardiovascular
diseas
shown
plasma
fibrinogen
level
increas
copd
patient
thu
make
suscept
ischem
event
exacerb
found
increas
level
plasma
fibrinogen
stimul
product
fibrinogen
level
higher
presenc
viral
infect
epidemiolog
studi
suggest
infect
especi
respiratori
tract
may
involv
onset
myocardi
infarct
stroke
patient
frequent
exacerb
recurr
infect
may
particularli
suscept
cardiovascular
diseas
airway
bacteri
colon
found
approxim
copd
patient
shown
relat
degre
airflow
obstruct
current
cigarett
smoke
statu
although
bacteria
haemophilu
influenza
streptococcu
pneumonia
associ
copd
exacerb
studi
shown
increas
bacteri
count
exacerb
other
confirm
soler
colleagu
show
presenc
potenti
pathogen
organ
bal
fluid
copd
patient
obtain
bronchoscopi
associ
greater
degre
neutrophilia
higher
tumor
necrosi
level
larger
studi
hill
colleagu
show
airway
bacteri
load
relat
presenc
inflammatori
marker
also
found
type
bacteri
speci
relat
degre
inflamm
pseudomona
aeruginosa
colon
show
greater
myeloperoxidas
activ
indirect
measur
neutrophil
activ
exacerb
associ
purul
sputum
like
produc
posit
bacteri
cultur
exacerb
sputum
product
mucoid
sethi
colleagu
shown
exacerb
associ
h
influenza
moraxella
catarrhali
associ
significantli
higher
level
airway
inflammatori
marker
neutrophil
elastas
compar
pathogenneg
exacerb
thu
bacteri
colon
patient
copd
may
import
determin
airway
inflamm
longterm
studi
requir
discern
whether
bacteri
colon
predispos
patient
declin
lung
function
characterist
copd
howev
also
possibl
may
interact
viral
bacteri
infect
copd
exacerb
organ
chlamydia
pneumonia
associ
asthmat
exacerb
also
may
play
role
copd
exacerb
evalu
requir
consider
interest
effect
air
pollut
copd
exacerb
especi
respect
effect
common
pollut
hospit
admiss
copd
patient
found
increas
number
hospit
admiss
suggest
increas
number
exacerb
increas
environment
pollut
occur
decemb
pollut
episod
unit
kingdom
copd
mortal
rate
increas
togeth
increas
hospit
admiss
among
elderli
copd
patient
data
studi
air
pollut
six
european
citi
air
pollut
health
european
approach
project
show
rel
risk
copd
hospit
admiss
due
increas
gm
daili
mean
level
pollut
lag
day
total
suspend
particl
ozon
analysi
data
birmingham
al
also
show
inhal
particl
carri
rel
risk
hospit
admiss
copd
gener
convinc
relationship
hospit
admiss
due
copd
level
particul
pollut
studi
also
shown
relationship
exposur
studi
australia
suggest
increas
copd
hospit
admiss
exposur
although
consider
epidemiolog
data
increas
pollut
associ
copd
hospit
admiss
mechan
involv
larg
unknown
copd
exacerb
close
link
respiratori
infect
hypothesi
pollut
increas
suscept
viral
infect
propos
one
studi
investig
effect
exposur
control
chamber
suscept
infect
influenza
found
small
increas
effect
combin
viru
pollut
anoth
studi
investig
effect
person
exposur
risk
airflow
obstruct
asthmat
children
respiratori
infect
studi
suggest
higher
person
pollut
exposur
greater
risk
asthmat
exacerb
follow
respiratori
infect
thu
similar
mechan
may
oper
patient
copd
studi
requir
associ
pollut
infect
articl
describ
import
characterist
copd
exacerb
patient
copd
prone
frequent
exacerb
import
determin
health
statu
patient
higher
airway
cytokin
level
suggest
increas
airway
inflamm
could
increas
patient
suscept
exacerb
inflammatori
respons
copd
exacerb
variabl
rise
level
exacerb
relat
presenc
common
cold
rhinoviru
infect
import
etiolog
factor
copd
exacerb
import
target
prevent
therapi
reduct
copd
exacerb
import
impact
consider
morbid
mortal
associ
copd
